mutations and complex kar yotype. It follows a linear evolution in the CLL clone in the recurrent acquisition of CDKN2AGenetic susceptibility mechanisms. Most susceptibility loci map to non-coding regions in the genome, are predominantly situated in Lively promoters or enhancers, and modify the binding web-sites of a variety of transcription elemen